Pablo García de Frutos

Head of Department

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Pablo García de Frutos is the Head of Department at IIBB-CSIC in Spain. His research focuses on various aspects of cancer biology, including the mechanisms underlying pancreatic and hepatocellular carcinoma, as well as cardiovascular health in heart failure patients. He has published extensively on the implications of myeloid cells in atherosclerosis and the impact of tyrosine kinase inhibitors on the inflammasome pathway.

Articles (11)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (16)

SUSANA CAMPUZANO RUIZ

Full Professor

Universidad Complutense de Madrid

SPAIN

Pablo García de Frutos

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Induction of the Inflammasome Pathway by Tyrosine Kinase Inhibitors Provides an Actionable Therapeutic Target for Hepatocellular Carcinoma

Hallmarks of pancreatic cancer: spotlight on TAM receptors

Electrochemical immunoplatform to help managing pancreatic cancer

Prognostic Value of Soluble AXL in Serum from Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection Fraction

Atherosclerotic plaque development in mice is enhanced by myeloid ZEB1 downregulation

Impaired Antibody Response Is Associated with Histone-Release, Organ Dysfunction and Mortality in Critically Ill COVID-19 Patients

Direct actions of dapagliflozin and interactions with LCZ696 and spironolactone on cardiac fibroblasts of patients with heart failure and reduced ejection fraction.

Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances

Impaired Antibody Response Is Associated with Histone-Release, Organ Dysfunction and Mortality in Critically Ill COVID-19 Patients

Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances

Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis

Collaborators (16)

SUSANA CAMPUZANO RUIZ

Anna Colell

Joram Huckriede

Pedro Moliner

Ana Paula Dantas

Maria Reig

Stephanie Franzén

Gerry Nicolaes

Pilar Navarro

Marlies Cortés

Rut Andrea

M Carmen Martinez-Campanario

Luis Ortega-Paz

Anders Bergqvist

Miklós Lipcsey

Josep Comin‐Colet

Make your next move.